您的购物车当前为空
别名 L-45
L-45 is the first potent and cell-active bromodomain (Brd) inhibitor of p300/CBP-associated factor (PCAF) (Kd: 126±15 nM).

L-45 is the first potent and cell-active bromodomain (Brd) inhibitor of p300/CBP-associated factor (PCAF) (Kd: 126±15 nM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | 待询 | 5日内发货 | |
| 25 mg | ¥ 26,200 | 8-10周 | |
| 50 mg | ¥ 31,200 | 8-10周 | |
| 100 mg | ¥ 42,300 | 8-10周 |
| 产品描述 | L-45 is the first potent and cell-active bromodomain (Brd) inhibitor of p300/CBP-associated factor (PCAF) (Kd: 126±15 nM). |
| 靶点活性 | BRD:126 nM (kd) |
| 体外活性 | L-45 binds in the acetylated lysines (KAc) -binding pocket of PfGCN (blue ribbon and sticks) and makes H-bonds (dotted lines) through the triazole to N1436 and the first of a network of four water molecules (red spheres). A structure using highly homologous (64?% identity) Brd from Plasmodium falciparum, PfGCN5, of which L-45 is also a potent ligand (isothermal titration calorimetry (ITC) KD 280 nM), is successfully obtained (PDB: 5TPX). L-45 disrupts PCAF-Brd histone H3.3 interaction in cells using a nanoBRET assay, and a co-crystal structure of L-45 with the homologous Brd PfGCN5 from Plasmodium falciparum rationalizes the high selectivity for PCAF and GCN5 bromodomains [1]. |
| 体内活性 | In human and mouse liver microsomes, L-45 displays no observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell-permeability, and metabolic stability. It also supports its potential for in vivo use[1]. |
| 别名 | L-45 |
| 分子量 | 360.46 |
| 分子式 | C21H24N6 |
| CAS No. | 2079885-05-3 |
| 密度 | 1.22 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多